AMNEAL PHARMACEUTICALS, INC. Estimated Litigation Liability, Noncurrent
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Estimated Litigation Liability, Noncurrent of $70.83 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:LitigationReserveNoncurrent · last filed 2026-08-06
- 2026-06-30: Estimated Litigation Liability, Noncurrent $70.83M.
- 2026-03-31: Estimated Litigation Liability, Noncurrent $70.02M.
- 2025-12-31: Estimated Litigation Liability, Noncurrent $71.82M.
- 2025-09-30: Estimated Litigation Liability, Noncurrent $74.48M.
| Period end | Estimated Litigation Liability, Noncurrent |
|---|---|
| 2026-06-30 | $70.83M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $70.02M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $71.82M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $74.48M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $74.48M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $72.98M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $85.48M 10-K · filed 2026-02-27 |
| 2024-09-30 | $85.48M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $85.48M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $85.48M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $316.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $486.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $752.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 |
| 2022-12-31 | $49.44M 10-K · filed 2024-03-14 |
| 2022-09-30 | $48.73M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $48.01M 10-Q · filed 2022-08-08 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |